InMed Pharmaceuticals
18 hedge funds and large institutions have $65K invested in InMed Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$6K |
| 2 |
2
Renaissance Technologies
New York
|
$23K |
| 3 |
AC
3
Armistice Capital
New York
|
$450 |
Top Sellers
| 1 |
EAM
1
Empery Asset Management
New York
|
$0 |
| 2 |
2
Two Sigma Advisers
New York
|
$23K |
| 3 |
3
Two Sigma Investments
New York
|
$0 |
| 4 |
TSS
4
Two Sigma Securities
New York
|
$0 |
| 5 |
5
Millennium Management
New York
|
$0 |
